Effects of a new flavonoid and Myo-inositol supplement on some biomarkers of cardiovascular risk in postmenopausal women: a randomized trial.

ABSTRACT: Background and Aim. Cardiovascular risk is increased in women with menopause and metabolic syndrome. Aim of this study was to test the effect of a new supplement formula, combining cocoa polyphenols, myo-inositol, and soy isoflavones, on some biomarkers of cardiovascular risk in postmenopausal women with metabolic syndrome. Methods and Results. A total of 60 women were enrolled and randomly assigned (n = 30 per group) to receive the supplement (NRT: 30?mg of cocoa polyphenols, 80?mg of soy isoflavones, and 2?gr of myo-inositol), or placebo for 6 months. The study protocol included three visits (baseline, 6, and 12 months) for the evaluation of glucose, triglycerides, and HDL-cholesterol (HDL-C), adiponectin, visfatin, resistin, and bone-specific alkaline phosphatase (bone-ALP). At 6 months, a significant difference between NRT and placebo was found for glucose (96 ± 7 versus 108 ± 10?mg/dL), triglycerides (145 ± 14 versus 165 ± 18?mg/dL), visfatin (2.8 ± 0.8 versus 3.7 ± 1.1?ng/mL), resistin (27 ± 7 versus 32 ± 8?µg/L), and b-ALP (19 ± 7 versus 15 ± 5?µg/mL). No difference in HDL-C concentrations nor in adiponectin levels between groups was reported at 6 months. Conclusions. The supplement used in this study improves most of the biomarkers linked to metabolic syndrome. This Trial is registered with NCT01400724.

SUBMITTER: D'Anna R 

PROVIDER: S-EPMC4164131 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature